Assays of Lactate Dehydrogenase /LDH-L and LDH-P/, Malate Dehydrogenase /MDH/ and Olucose-6-Phosphate Dehydrogenase /G6PDH/ were done weekly on cultured adipocytes and skin fibroblasts grown in synthetic medium and obese serum. Levels of MDH was similar in adipocytes and skin fibroblasts, while the levels of LDH-L, LDH-P and G6PDH were lower in adipocytes than in s m fibroblasts. After transformation to a fibroblast-like appearance, in culture, the adipose cells /now termed adipofibroblasts/ contain significantly more of each enzyme than did the initial adipose cell isolates. The levels of activities of LDH-L, LDH-P and G6PDH increased to the same levels as in skin fibroblasts, however MDH activities rose to much higher levels than those found in skin fibroblasts. In obese serum, activities of LDH-L, LDH-P did not significantly change but the activities of Y-DH and G6PDH dropped sharply in adipofibroblasts, when as in cultures of skin fibroblasts only the G6PDH activities dropped significantly, the other enzyme activities being unchanged. On the basis of these and other data it is conclued that adipose cells are not just fibroblasts with lipid-storing ability. Hyp&-lipoproteinemia I pattern was found in three 14,11,6 year old siblings by LPelectrophoresis and ultracentrifugation. Chylomicrons were inducable by 50% dietary fat, not carbohydrate. Bone maturation was delayed, thyroid function normal. All had stunted growth STH levels after arginine, insulin, glucose were normal. 1.v. glucose loading revealed increased glucose assimilation. Stimulation of lipolysis in vivo with glucagon and orciprenaline /loo ng/kg/&mf was significantly lower /p<o.ol resp.<o.o25/ than in unaffected controls. During these stimulations plasma levels of cABP increased to significantly higher levels /p<o,o5 resp.<o.o25/ than in controls. These results indicate a defect in adenylcyclase-CAMP-proteinkinase-triglyceridlipase system. Since plasmatic cABP rises to higher levels than normal we assume that the CAMP binding enzyme, proteinkinase, is deficient or inactive in the lipolytic cascade and in glycogen metabolism. In order the study metabolic rate and temperature lahoma Kedical Research Foundation, Oklahoma City,USA control under controlled thermal conditions, we conTo test the feasibility to differentiate intrahepastructed a closed-circuit respirometer for newborn intic from extrahepatic cholestasis with the test for fants which permits the simultaneous measurement of LP-X/cholestatic serum lipoprotein/, we have initialoxygen consumption rate /Vo /, and body and environly examined sera from 38 infants with CJ by immunoelmental temperatures. A tot31 of 178 exams have been ectrophoresis. LP-X was absent in 19 with neonatal heperformed on 62 newborn infants. Over the first five patitis, but present in 16 inf'ants with biliary atreweeks of extrauterine life, minimal Vo2 expressed per sia /BA/and in 3 with severe intrahepatic cholestasis.
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unit surface area or per unit body weight rises subsTo further charactel-ize CJ in LP-X positive infants, tantially. The neutral pperative temperature falls we attempted to influence serum LP-X witn cholestyraprogressively. Both rectal-environmental and mean skin mine /CSM/, a non-absorbable bile acid binding resin.
-environmental temperature gradients rise. Ambient During a two week /4grn/day/ administration of CSL1,LPthermal insulation is slightly low in comparison with X increased /p>o.l/ in all 13 infants with BA, wherthe adult, and tissue insulation is substantially loeas it decreased /p<pa25/ in all 7 infants with intwer. Studies in babies under looo grams birthweight rahepatic cholestaais.LP-X negative infants /47mo/neshow the importance of gestational age differences ever had BA.The effect of CSN on lowering serum LP-X ven in this weight group in determining metabolic rate in im-ants with patent extrahepatic bile ducts is medtotal specific thermal insulation, and neutral operaiated via a predictable alteration of bile acid metative temperature. These observations allow the first bolism by CSI:;: increased fecal excretion and increasestimate of the caloric requirement for extra-uterine ed hepatic synthesis from cholesterol. The ensuing rigrowth in prematurely born infants, based on concurrse of hepatobiliary excretion of bile acids is associently measured differences in their metabolic rates. ated with similarly enhanced excretion of cholesterol and phospholipids.These events lower serum cholesterol and phospholipids, the major constituents of LP-X
